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Mediation of proteinuria in membranous nephropathy due to a planted
glomerular antigen. In experimental membranous nephropathy in rats
(passive Heymann nephritis) subepithelial immune deposits result from
in situ reaction of heterologous (sheep) antibody against rat proximal
tubular brushborder antigen (FxIA) with an endogenous glomerular
antigen. We have previously shown that the proteinuria which results is
complement-dependent but neutrophil-independent. To investigate the
mediation of glomerular injury induced when subepithelial deposits
result from antibody binding to an exogenous antigen planted in the
glomerulus, rats were injected with subnephritogenic doses of noncom-
plement fixing sheep y2 anti-rat Fx IA IgG which produced subepithelial
deposits of sheep IgG without morphologic or functional evidence of
glomerular injury. When kidneys from these donor rats were transplant-
ed into bilaterally nephrectomized recipients preimmunized with sheep
IgG, the deposits of sheep IgG served as a planted antigen to initiate
subepithelial immune complex formation and proteinuria. Five days
after transplantation, recipients of antigen-containing kidneys had sub-
epithelial deposits of sheep IgG, rat lgG, rat C3, and proteinuria.
Proteinuria did not occur at 5 days in recipients of antigen-containing
kidneys that were immunosuppressed by sublethal irradiation or com-
plement-depleted with cobra venom factor (CVF); recipients of normal
rat kidneys were not proteinuric. When recipients of antigen-containing
kidneys were passively immunized with rat anti-sheep IgG, proteinuria
at 2 days was not affected by either selective neutrophil depletion or
pancytopenia induced by lethal irradiation. Proteinuria was also com-
plement-dependent in intact rats in which in situ subepithelial immune
complex formation was induced in 7 to 8 days by preimmunization with
sheep IgG followed by injection of y2 sheep anti-rat FxIA. These
results demonstrate that glomerular injury in experimental membranous
nephropathy in rats is complement-dependent but cell-independent
when deposit formation is initiated by antibody reacting with an
exogenous sheep IgG antigen planted in the glomerulus as well as with
an endogenous glomerular antigen. They suggest that this new mecha-
nism of glomerular injury may be relevant to all forms of membranous
nephropathy.
Mediation de Ia protéinurie dans Ia néphropathie extra-membraneuse
par un antigène glomerulaire implanté. Dans la néphropathie extra-
membraneuse expérimentale chez le rat (nephrite passive de Hey-
mann), les dépôts immuns sous épithéliaux résultent de Ia reaction in
situ d'anticorps heterologues (mouton) contre un antigène de bordure
en brosse tubulaire proximale de rat (FxlA) avec un antigène glomeru-
laire endogene. Nous avons montré préalablement que Ia protéinurie
qui en résulte est dépendante du complement mais indépendante des
neutrophiles. Afin d'étudier la mediation de Ia lesion glomerulaire
induite lorsque les dépôts sous épitheliaux résultent de Ia liaison d'un
anticorps a un antigène exogéne implanté dans Ic glomérule, des rats
ont recu des injections de doses infranephritogènes d'IgG y2 de mouton
ne fixant pas le complement anti FxIA de rat, qui produisaient des
dépôts sous epithéliaux d'IgG de mouton sans preuve morphologique ni
fonctionnelle d'atteinte glomerulaire. Lorsque les reins de ces rats
donneurs étaient transplantes a des receveurs binephrectomises préim-
munisés avec de l'IgG de mouton, les depots d'IgG de mouton étaient
utilisés comme un antigène implanté pour initier Ia formation d'immuns
complexes sous épitheliaux et Ia protdinurie. Cinq jours après Ia
transplantation, les receveurs de reins contenant de l'antigene avaient
des dépôts sous épithéliaux d'IgG de mouton, d'IgG de rat, de C 3 de
rat, et une protéinurie. La protCinurie ne survenait pas au bout de 5
jours chez les receveurs de reins contenant de l'antigene, immuno-
supprimés par irradiations subléthales ou déplétés en complement par
du facteur de venin de cobra (CVF); les receveurs de reins de rat normal
n'étaient pas protéinuriques. Lorsque les receveurs de reins contenant
de l'antigene étaient immunisés passivement avec de l'IgG de rat
antiomouton, Ia protéinurie au 2 jours n'était pas affectée par Ia
depletion selective en neutrophiles. La protéinurie était egalement
dépendante du complement chez des rats intacts chez qui Ia formation
in situ de complexes immuns sous épithéliaux était induite en 7 a 8jours
par immunisation prealable avec de l'IgG de mouton suivie par une
injection de y2 de mouton anti-rat Fx1A. Ces résultats démontrent que
la lesion glomérulaire dans Ia néphropathie extramembraneuse expéri-
mentale chez le rat est dépendante du complement mais independante
des cellules lorsque Ia formation de depots est initiée par un anticorps
réagissant avec un antigéne IgG exogène de mouton implante dans Ic
glomerule, et par un antigéne glomerulaire endogène. Ils suggèrent que
ce nouveau mécanisme de lesion glomerulaire pourrait avoir une significa-
tion dans toutes les formes de nephropathie extramembraneuse.
Inflammatory mediators produced by activation of the classi-
cal or alternate complement pathways are well recognized
contributors to antibody-induced tissue damage [1]. The princi-
pal established role for complement in renal injury involves the
attraction of neutrophils via immune adherence mechanisms
involving C3b receptors or the generation of leukochemotactic
factors such as C5a [2—4]. However, this mechanism has so far
been demonstrated only in certain models of glomerulonephritis
induced with heterologous anti-GBM antibodies (nephrotoxic
nephritis) and is characterized by clear morphologic evidence of
glomerular inflammation as well as functional changes including
proteinuria [2, 5, 6].
Recently, we demonstrated a new role for complement in
mediating glomerular injury in experimental membranous
nephropathy [7]. In the passive Heymann nephritis (PHN)
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Transplant model
Group 1—Active
immunization
A Experimental (N = 9)a
B Control—No planted
Ag (N = 4)
C Immunosuppressed
(N =3)
D Complement depleted(N — 4)
Group 2—Passive
immunization
A Neutrophil depleted
(N — 4)
Control (N 4)
B Pancytopenic (N = 3)
Control (N = 3)
Native kidney model
Group 3
A Experimental
(N= 11)
B Control (N = 4)
C L-asparaginase
(N = 5)
D Sublethal irradiation
(N -5)
E Complement depleted
(N =5)
model, proteinuria results from the direct glomerular binding of
heterologous antibody (anti-FxlA) to a fixed glomerular antigen
[8, 91. Proteinuria in PITIN is entirely complement-dependent
but, unlike nephrotoxic nephritis, there is no associated glomer-
ular cellular infiltrate in PHN, and lethal irradiation or specific
neutrophil depletion have no effect on this form of complement-
dependent glomerular injury [7].
To examine the hypothesis that this new complement-depen-
dent, cell-independent mechanism may also be operative when
subepithelial immune deposit formation occurs as a conse-
quence of antibody binding to a planted exogenous antigen, we
utilized the observations in PHN to develop a new model of
membranous nephropathy. We utilized small doses of the
noncomplement fixing y2 subclass of sheep antibody to Fx1A
as antigen which localizes immunologically in the subepithelial
space without causing detectable morphologic or functional
glomerular injury [7]. When kidneys containing the y2 sheep
IgG as a planted subepithelial antigen are transplanted into
isogeneic recipients, in situ subepithelial immune deposit for-.
mation and proteinuria ensue when anti-sheep IgG antibody
reacts with the planted antigen. Results of studies with this
model confirm our previous studies in the fixed antigen model
and support the hypothesis that this new complement-depen-
dent, noninflammatory mechanism of glomerular damage may
be generally applicable to the mediation of proteinuria induced
by subepithelial immune deposits formed in situ regardless of
the mechanism which initiates deposit formation.
Methods
Experimental design
In the model used for most experiments, subncphritogenic
doses of sheep y2 anti-rat-Fx1A IgG were first injected into
normal donor rats. After waiting 3 days for enough of this
antibody IgG to localize in the subepithelial space to serve as a
planted antigen [10], donor kidneys with planted antigen were
transplanted into bilaterally nephrectoniized recipient rats that
were either actively immunized 6 days earlier with 1 mg of
sheep IgG in complete Freunds adjuvant (CFA) (DLFCO
Laboratories, Detroit, Michigan) or passively immunized with
rat anti-sheep lgG at the time of transplantation. Thus, in situ
immune complex formation involving rat antibody and sheep
antigen occurred in the transplanted kidney from the time of
transplantation in the absence of complex formation in the
circulation. In most animals, renal function, urine protein
excretion and renal histology, immunofluorescence, and ultra-
structure were examined at intervals up to 5 days after the
transplant. Various groups of animals were studied to charac-
terize the model and to assess the role of complement and cells
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Table 1. Glomerular IF and protein excretion in models of membranous nephropathy due to planted antigen
Glomerular IF Urine pro- Serum
tein excretionb creatinin&'
Rat C3Sheep IgG Rat IgG mg/day mg/dl
Day.s 4 to 5 Day 5
33 23 (8.4 to 88) 1.2 0.1
3,6 + 1.8 (1.0 to 4.8) 1.2 0.1
0.6 0.1 (0.6 to 0.7) 0.8 0.1
1.8 0.4 (1.3 to 2.1) 1.1 0.2
Days I to 2 Day 2
+
+
+
+
+
+
.4-
+
Trace
+
+
+
+
+
+
+
+
87 - 50
84 72
112 95
127 103
(22 to l43)
(25 to 190)
(49 to 222)d
(52 to 245)
I.! 0.1
1.2 0.1
1.1 0.1
1.1 0.1
Days 7 to 8 Day 8
+ Trace Trace
+ Trace Trace
+ +
28 + 36 (1.4 to l02)
1.0 0.2 (0.9 to 1.2)
1.1 0.3 (0.8 to 1.5)'
1.5 0.5 (1.1 to 2.2)d
N — number studied.
All values are mean 1 su; the range of values is in parentheses.
Significantly greater than control (P < 0.02).
"Not significantly different from control (P > 0.05).
Two animals that were not adequately depleted for the entire experiment had trace deposits of rat C3.
0.8 0.1
0.9 0.1
0.8 0.1
0.9 0.1
1.7 1.1 (0.9 to 37)" 0.8 0.1
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n mediating the proteinuria which resulted. These groups are
summarized in Table 1. Details of the technical procedures used
ire outlined below. Lewis rats (M. A. Bioproducts, Walkers-
yule, Maryland) were used in group 1 and Sprague-Dawley (SD)
rats (C. B., Charles River Breeding Laboratories, Wilmington,
4assachusetts) in groups 2 and 3.
Group IA. In the unmodified experimental group, nine rats
that were pre-immunized with sheep IgG received a y2 sheep
LgG antigen-containing transplant and were studied at intervals
ip to 5 days later. In an additional three recipients, one host
kidney was left in place to detect deposition of any circulating
immune complexes that might form if antigen were released
Irom the transplanted kidneys.
Group lB. To exclude any possibility that the pre-immuniza-
tion or transplant procedure themselves altered kidney mor-
phology or protein excretion after transplantation, four pre-
immunized recipients received kidneys from donors that had
been given only nonantibody sheep 72 3 days prior to transplan-
tation and therefore had no antigen in the transplanted kidney.
Group IC. Todemonstrate that the proteinuria in the antigen-
containing transplants was mediated by the reaction of rat
antibody with the planted sheep IgG, this reaction was prevent-
ed in three non-immunized rats that received antigen-containing
kidneys and were immunosuppressed by sublethal irradiation
on the day prior to transplantation.
Group ID. To test the role of complement in mediating the
proteinuria in this model, four pre-immunized rats received
antigen-containing kidneys but were depleted of C3 for 5 days
by daily injection of CVF beginning the day prior to
transplantation.
Group 2A. To evaluate the role of neutrophils, four rats
received antigen-containing kidneys but were depleted of neu-
trophils with specific rabbit anti-neutrophil serum for 1 day
before and 2 days after transplantation. Because pre-immuniza-
tion with IgG precluded effective neutrophil depletion, these
animals received rat anti-sheep IgG antibody passively immedi-
ately following transplantation. Four control rats were treated
the same way but were given normal rabbit serum instead of
anti-neutrophil serum. In addition to measurements made in
other groups, renal tissue samples were obtained in this group
after 4, 24, and 48 hr and examined by light microscopy and IF.
Group 2B. To further exclude a role for other circulating cells
in mediating proteinuria in this model, three rats were rendered
pancytopenic by lethal irradiation administered 2 days prior to
the transplantation of an antigen-containing kidney and were
then passively immunized with rat anti-sheep IgG as in group
2A. A separate control group of three rats received the same
treatment but was not irradiated.
Verification of the results in the transplant model was ob-
tained in separate studies of non-transplanted native kidneys
(group 3). Rats were pre-immunized with 1 mg of sheep IgG in
CFA (DIFCO Laboratories) and 5 days later were given an intra-
venous injection of 8mg of 72 sheep anti-rat FxIA (group 3A, N
= 11) or y2 nonantibody sheep IgG (group 3B, N = 4). In this
native kidney model, proteinuria developed only 7 to 8 days
after injection of sheep anti-rat FxlA. By immunosuppression
of non-immunized rats with L-asparaginase (group 3C, N = 5)
or sublethal irradiation (group 3D, N = 5) before 72 anti-Fx1A
administration, proteinuria was prevented and shown to result
from autologous rat antibody binding to planted sheep IgG. The
effect of complement depletion was studied by treating five pre-
immunized rats given y2 anti-FxlA with daily doses of CVF for
8 days before sacrifice (group 3E, N = 5).
Preparation and characterization of y2 sheep anti-rat FxIA
Sheep were hyperimmunized with rat Fx1A, prepared as
described by Edgington, Glassock, and Dixon [111, from fresh
rat renal cortices and emulsified in CFA (DIFCO Laboratories).
After 3 to 4 monthly injections of 75 to 100 mg of Fx1A, sheep
serum was collected and heat-inactivated (56°C, 30 mm). The
72, noncomplement-fixing subclass of sheep IgG was isolated
from a 50% ammonium sulfate precipitate of whole antiserum
by ion-exchange chromatography on DEAE-Sephacel (Pharma-
cia Fine Chemical, Inc., Piscataway, New Jersey) using 0.0 175
M sodium phosphate buffer, pH 7.4. The y2 IgG peak, eluted in
the void volume, was pooled and concentrated in an Amicon
PM-30 ultrafilter (Amicon Corp., Scientific Systems Division,
Lexington, Massachusetts) to approximately 8 mglml and
stored at —70°C until used.
Purity and specificity of 72 anti-rat FxlA were assessed by
immunoelectrophoresis and micro-Ouchterlony immunodiffu-
sion [12, 13] in 1% agarose gels against rat serum and antiserum
to whole sheep serum (Miles Laboratories, Inc., Elkhart,
Indiana), and sheep IgG (Cappel Laboratories, Inc., Cochran-
yule, Pennsylvania). The in vitro complement-fixing ability was
assessed by indirect IF as described under tissue processing
below. In all studies where sheep IgG was used as the planted
antigen, rats were given 8 mg of y2 sheep anti-rat FxlA IgG
intravenously. Previous studies have shown that this dose of
antibody produces subepithelial deposits which do not cause
heterologous phase proteinuria or morphologic changes and do
not fix complement in vivo [71. Controls received equivalent
doses of nonantihody y2 sheep IgG.
The protein concentrations of purified preparations of sheep
IgG were determined by measuring light absorption (E nm =
14).
Preparation and characterization of rat anti-sheep IgG
Male SD rats, weighing 150 to 175 g, (CD, Charles River
Breeding Laboratories) were immunized repeatedly with an
emulsion of purified sheep IgG (Miles Laboratories, Inc.) in
CFA. One week after the last immunization, serum was collect-
ed from all rats with anti-sheep IgG activity demonstrable by
micro-Ouchterlony immunodiffusion. Serum was pooled, heat-
inactivated and stored at —70°C until used. Activity and speci-
ficity of the antiserum were assessed by immunoelectrophoresis
and micro-Ouchterlony immunodiffusion against sheep serum
and sheep IgG (1 mg/ml). Precipitin lines were seen against both
sheep IgG and 1gM in whole serum. When in situ immune
complex formation was induced by passive administration of rat
anti-sheep IgG, doses of 1.5 (group 2B) or 2.0 (group 2A) ml of
whole antiserum with a precipitin titer of 1:4 were given
intravenously.
Preparation and characterization of rabbit anti-rat neutrophil
serum and neutrophil depletion studies
Anti-rat neutrophil serum was prepared by immunizing rab-
bits with rat peritoneal exudate cells as previously described
[71. The antiserum was absorbed with lyophilized rat serum,
neutrophil-free rat erythrocytes and rat lymphocytes and thy-
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mocytes obtained from rat mesenteric and cervical lymph nodes
and thymuses [71. The globulin fraction of the absorbed antise-
rum was isolated by a single, 50% ammonium sulfate precipita-
tion and redissolved in one half of the original volume of 0.02 M
phosphate-buffered saline, pH 7.2. After extensive dialysis
against the same buffer it was stored at —70°C.
Neutrophil-depletion in group 2A was achieved by daily
administration of 2.5 ml of the globulin fraction of anti-neutro-
phil serum in divided doses, intravenous and intraperitoneal,
starting the day prior to transplantation and continuing for 2
days thereafter. Controls received equivalent doses of normal
rabbit serum. Peripheral blood leukocyte counts were measured
daily using a Coulter Counter, model ZBI (Coulter Electronics
Inc., Hialeah, Florida), and the percentage of neutrophils was
determined by counting 200 cells on a peripheral smear stained
with Wright's stain.
Complement depletion of rats
Purified cobra venom factor (CVF), obtained from Naja naja
Kaouthia (Cordis Laboratories, Inc., Miami, Florida), was
dissolved in triple distilled water at 0°C and then frozen at
—70°C until used. Rats in groups ID or 3E were depleted of C3
and later reacting complement components by intraperitoneal
injection of a total of 300 U/kg of CVF in four divided doses
beginning 24 hr before injection of antibody or transplantation
of a kidney. This was followed by daily injections of CVF, 100
U/kg i.p., as described by Cochrane, Müller-Eberhard, and
Aiken [14], for the duration of the experiment. Serum C3 levels
were measured daily by single, radial immunodiffusion [15] and
expressed as a percentage of the levels present in pooled, fresh,
normal rat serum.
Renal transplantation
Male SD rats, 190 to 250 g (CD, Charles River Breeding
Laboratories), or Lewis rats, 225 to 300 g (M. A. Bio-Products),
were used. The left kidneys of donor rats were orthotopically
transplanted into unilaterally or bilaterally nephrectomized
recipients using a modification of the technique of Lee [16].
Donor kidneys were gently perfused with 3 ml of chilled,
heparinized RPM! medium (GIBCO, Grand Island, New York)
prior to removal. A short segment of donor aorta and a vena
caval cuff were left attached to the renal artery and vein,
respectively. End-to-side anastomoses were then performed to
the recipient aorta and inferior vena cava. The donor and
recipient ureters were anastomosed end-to-end over a short
piece of 0.025-inch O.D. silastic tubing (Dow Corning Corp.,
Midland, Michigan) as suggested by Daniller, Buchholz, and
Chase [171. After removing the vascular clamp, kidneys re-
gained good color almost immediately and most kidneys pro-
duced urine soon thereafter. Adequacy of renal function was
assessed by daily determination of serum creatinine (Worthing-
ton Diagnostics, Freehold, New Jersey).
Immunosuppression
Rats immunosuppressed with sublethal irradiation (groups 1C
and 3D) received 658 Rads of total body radiation the day
before antibody injection. Radiation was administered from a
dual source '37Cs small animal irradiator (Gammocell 40, Atom-
ic Energy of Canada Ltd., Toronto, Canada) at a dose rate of
129 Rad/min. Pancytopenia in group 2B was effected by admin-
istration of 942 Rads of total body irradiation from the same
source 48 hr prior to transplantation.
Rats immunosuppressed with L-asparaginase (group 3C) re-
ceived 2000 U/kg/day i.p. starting the day before antibody
injection and continuing on a daily basis for the duration of the
study.
Tissue processing and IF procedures
Tissue for light microscopy was fixed in 10% neutral-buffered
formalin, sectioned at 4 t and stained with hematoxylin and
eosin and periodic acid-Schiff reagent. Direct and indirect IF
procedures were performed on tissue snap-frozen in dry ice
isopentane, sectioned at 4 s in a cryostat, and fixed in ether-
alcohol as described previously [9, 181. All biopsy specimens
were stained with the fluoresceinated IgG fraction of monospe-
cific antisera to sheep IgG, rat lgG (Cappel Laboratories) and
rat C3, prepared as previously described [7]. Antibody to rat
IgG was not cross-reactive with sheep lgG by immunoprecipitin
or IF analysis.
In vitro C3 fixation was assessed as described previously [7]
on washed, fixed cryostat sections of normal rat kidney which
had been incubated with different subclasses of sheep anti-
Fx1A lgG, or on washed, unfixed sections from rats previously
injected with one of the two antibody subclasses. Sections
containing antibody deposits were incubated with dilutions of
fresh or heat-inactivated, human serum in veronal buffer at 25°C
for 60 mm followed by washing and staining for human C3 by
direct IF. IF was evaluated and photographed on a Leitz
Ortholux II microscope equipped with a Ploempak 2.2 vertical
fluorescence illuminator (E. Leitz, Inc., Rockleigh, New
Jersey).
Selected kidneys were perfusion-fixed at 120 mm Hg with
1.25 g/dl of glutaraldehyde in 0.1 M sodium cacodylate buffer,
pH 7.4 [19]. Fragments of renal cortex, fixed for I to 2 hr by
immersion in glutaraldehyde-paraformaldehyde mixture (2 g/dl
paraformaldehyde, 2.5 g/dl glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4) or by in vivo perfusion with glutar-
aldehyde (see above) were rinsed in cacodylate buffer, post-
fixed in 1 g/dl of aqueous osmium tetroxide for 2 hr, dehydrated
in graded ethanols, cleared in propylene oxide, and embedded
in epoxy resin. One-micrometer thick sections and ultra thin
sections (grey-silver interference color) were cut on an LKB-
Ultrotome. Thick sections were stained with toluidine blue and
thin sections were stained on the grid with uranyl acetate and
lead citrate and examined in a Philips 201 electron microscope.
Statistical analysis
Results of urine protein excretion were evaluated by the
Mann-Whitney U test for the analysis of nonparametric data
[201. All values are expressed as mean I SD unless otherwise
indicated.
Results
Characterization of-y2 sheep anti-rat FxJA. The more cation-
ic y2 sheep anti-rat Fx1A, which eluted from DEAE-Sephacel
with starting buffer, made a single precipitin line in micro-
Ouchterlony and a single arc in the lgG region on immunoelec-
trophoresis against anti-whole sheep serum. In micro-Ouchter-
lony, it made two lines against a 10 mg/mI suspension of rat
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Fig. I. Electron micro graph showing glomerular
capillary wall of an antigen-containing donor kidney
at the time of transplantation, 3 days after -y2 anti-
FxJA. There are numerous discrete subepithelial
electron dense deposits (arrows) present in the
lamina rara externa of the glomerular basement
membrane. Note the minimal distortion of the
epithelial foot processes. Abbreviations are: EC,
epithelial cell; E, endothelial cell; CL, capillary
lumen; US, urinary space. (x14,000)
Proteinuria in membranous nephropathy 811
Fx1A [11] and was unreactive with normal rat serum. By
indirect IF on normal rat kidney, antibody reactivity was
detected against proximal tubular brush border. As in past
studies [7], 72 sheep anti-Fx1A, bound to the brush border of
cryostat sections in vitro or deposited in glomeruli in vivo after
intravenous injection, did not fix human C3 in vitro or rat C3 in
vivo. Under similar conditions, the complement-fixing 71 sub-
class of sheep IgG fixed both human and rat C3 [7].
Proteinuria in transplanted kidneys. The results reported are
those in which the transplant was technically uncomplicated,
serum creatinine was less than 2.0 mgldl by 3 days post-
transplantation, and no ureteric obstruction was found at sacri-
fice. The results of IF studies and measurements of urine
protein excretion and serum creatinine 5 days after transplanta-
tion are presented in Table 1. Antigen-containing donor kid-
neys, at the time of transplantation, were normal by light
microscopy, had faint, granular glomerular capillary wall de-
posits of sheep IgG but no rat IgG or C3 by IF, and had discrete,
small, exclusively subepithelial electron dense deposits with
minimal foot process effacement by electron microscopy (Fig.
1). Experimental animals (group 1A, N = 9) in which the
transplant recipient was preimmunized 6 days before receiving
a kidney containing deposits of y2 anti-FxlA, had granular
glomerular capillary wall deposits of sheep IgG (1-2+), rat IgG
(1-3+), and rat C3 (1+) by direct IF and significant proteinuria
(33 23, range 8.4 to 88 mgld) on day 5 post-transplantation.
Tubular basement membrane deposits of sheep IgG and rat IgG
were also seen By light microscopy, glomeruli were unremark-
able except for an occasional segment of the tuft with mild
hypercellularity. The renal cortex showed multiple foci of
interstitial inflammation characterized by edema and inflamma-
tory cell infiltration with polymorphonuclear leukocytes and
mononuclear cells surrounding tubular elements. Individual
tubules showed nonspecific degenerative changes of the epithe-
hum and an occasional mitotic figure. These interstitial
changes, however, were not present at 2 days after transplanta-
tion. Ultrastructurally, electron dense deposits were found in
the subepithelial layer of the glomerular basement membrane
(Fig. 2). These deposits were composed of aggregates of
different electron densities and their frequency varied some-
what from one capillary loop to another. The overlying foot
processes often showed variable distortion, with partial separa-
tion from the basal lamina (Fig. 2) and extensive retraction and
obliteration (so called "fusion"). Mononuclear cells were found
in some capillary lumena in close apposition with, but not
displacing, endothelial cells. Three recipient rats, in which the
right kidney was left in place for 4 days following transplanta-
tion, had no glomerular deposits of sheep or rat IgG in the host
kidney, thereby excluding any role for circulating immune-
complex trapping in the disease that developed in the trans-
planted kidney. Controls (group lB, N = 4), in which the
transplant recipient was immunized with sheep IgG 6 days prior
to receiving a kidney from a rat given normal y2 sheep IgG, had
no glomerular deposits or proteinuria (3.6 1.8, range 1.0 to 4.8
mgld; P < 0.02 vs. group 1A) on day 5. Sublethal irradiation of
recipients prior to transplantation (group lC, N = 3) prevented
the appearance of rat IgG and rat C3 deposits and the develop-
ment of proteinuria on dayS (0.6 0.1, range 0.6 to 0.7 mgld).
Thus the development of proteinuria after transplantation re-
quired both the presence of the planted antigen and an intact
host immune response, and neither transplantation nor recipi-
ent preimmunization were themselves responsible for the
proteinuria.
Four preimmunized recipients (group lD) of antigen-contain-
ing kidneys that were treated with CVF had C3 levels main-
tained at less than 10% of pretreatment values for the full 5 days
of study. After 5 days, antigen-containing transplant kidneys in
complement-depleted, preimmunized recipients had granular,
glomerular capillary wall deposits of sheep IgG (Fig. 3A) and rat
IgG (Fig. 3B) identical to those in normo-complementemic, pre-
immunized recipients (group lA, Table 1). Glomerular C3
deposits were absent from all complement-depleted rats (Fig.
3C) and present (1+) in all normo-complementemic recipients
(Fig. 3D). Urine protein excretion in group 1D at 5 days was 1.8
0.4 mgld, (range 1.3 to 2.1 mgld, N = 4).
Role of cellular mediators in proteinuria
Antigen-containing kidneys which developed proteinuria
were examined histologically 4 hr and 1, 2, and 5 days after
us
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transplantation into preimmunized recipients. At no time were
proliferative changes or inflammatory cells seen in glomeruli;
capillary loops remained morphologically normal by light mi-
croscopy. Eight nonimmunized recipients of kidneys containing
subepithelial deposits of y2 sheep anti-FxIA (group 2A. Table
I) developed proteinuria following the passive administration of
rat anti-sheep IgG immediately after transplantation. Neutro-
phil (PMN) depletion was induced in four of these rats with anti-
PMN serum which reduced circulating neutrophil counts to less
than 200/mm3 from before administration of rat anti-sheep lgG
to the end of the study 2 days later. The other four rats had
1,144 to 3,034 PMN/mm3. Urine protein excretion on days I to
2 did not differ significantly between neutrophil-replete (84
72, range 25 to 190 mg/day) and neutrophil-depleted rats (87
50, range 22 to 143 mg/day; P> 0.8; Table 1).
Another group of six nonimmunized recipients of kidneys
containing subepithelial deposits of y2 sheep anti-Fx1A (group
2B) developed proteinuria following the passive administration
of rat anti-sheep IgG immediately after transplantation. Lethal
irradiation induced pancytopenia in three rats, and peripheral
monocytes were abolished or lowered to less than 10% of
control levels from the time of transplantation to the end of the
study. Urine protein excretion on days I to 2 did not differ
significantly between control (127 103, range 52 to 245
mg/day, N = 3) and pancytopenic animals (112 95, range 49 to
222 mg/day, N = 3; P > 0.3; Table 1).
Proteinuria in native kidneys. Rats given y2 anti-Fx1A i.v. 5
days following immunization with sheep IgG (group 3A, N =
11, Table 1) developed moderate, but significant proteinuria (28
36, range 1.4 to 102 mg/day) on days 7 to 8 when compared
with rats given nonantibody y2 (group 3B, N = 4) (1.0 0.2,
range 0.9 to 1.2 mg/day; P < 0.002). IF showed 2-3f granular,
glomerular capillary wall deposits of sheep and rat IgG and 1 +
deposits of rat C3 in group 3A but only trace mesangial deposits
of sheep IgG in two out of four rats in group 3B. Focal, 1 + TBM
deposits of sheep and rat IgG were also seen in group 3A.
Immunosuppression with L-asparaginase (group 3C, N = 5) or
sublethal irradiation (group 3D, N = 5) abolished proteinuria
and markedly decreased deposition of rat IgG and C3 in the
glomerular capillary wall (Table 1). Twenty-four-hour urine
Fig. 2. Electron micro graph of the glomerular
capillary wall ohm transplanted y2 anti-ExJA-
containing kidney in a preimmunized recipient. There
are numerous, irregular electron dense deposits
present in the subepithelial space of the basement
membrane (arrows). The overlying epithelial cell
(EC) shows obliteration of foot processes, partial
lifting of individual podocytes (arrowhead), and loss
of the epithelial slit diaphragm. Note also
mononuclear inflammatory cell (M) in the capillary
lumen. Abbreviations are: US, urinary space; CL,
capillary lumen. (x 14,000)
protein excretion in groups 3B, C, and D did not differ signifi-
cantly from that of age-matched, normal controls (upper 99%
confidence limit 3.5 mg/day, N = 20; P> 0.05). Thus, it was
confirmed that proteinuria was the result of rat antibody binding
to planted sheep IgG.
Five preimmunized rats (group 3E, Table 1) were given daily
injections of CVF beginning the day before antibody adminis-
tration and continuing for 8 days thereafter which maintained
serum C3 levels at less than 10% of initial values throughout in
three rats, while two animals had C3 levels rising to 62 and 67%
of normal over the last 2 and 4 days, respectively. Urine protein
excretion on days 7 to 8 was 1.7 1.1 mg/day, (range 0.9 to 3.7
mg/day, N = 5) in the CVF treated group compared to 28 36
mg/day (range 1.4 to 102.0 mg/day, N = 11; P < 0.02) in normo-
complementemic controls (group 3A). Proteinuria was
prevented in all five CVF treated animals including the two that
were not adequately depleted of complement for the last 2 and 4
days of the study. Glomerular deposits of sheep and rat IgG
were comparable by IF at 8 days in groups 3A and 3E. C3
deposits were abolished in rats that were adequately C3-
depleted but trace deposits of C3 were present in the two rats
that were not adequately depleted late in the experiment.
Discussion
This study tested the hypothesis that complement-dependent,
neutrophil-independent proteinuria in experimental membra-
nous nephropathy is characteristic of in situ, subepithelial,
immune deposit formation, and local complement-fixation initi-
ated by planted as well as fixed glomerular antigen. In previous
studies, in the passive Heymarin nephritis (PHN) model in rats,
we found a noninfiammatory, complement-mediated lesion was
the result of heterologous antibody reacting in situ with a fixed
glomerular antigen 7]. In the current studies, by using a
noncomplement-fixing subclass of sheep IgG antibody, it was
possible to plant an exogenous antigen in the glomeruli of rats
without producing any detectable glomerular injury. This in-
sured that subsequent proteinuria was the result of in situ,
subepithelial immune deposit formation due to the reaction of
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Fig. 3. Immunofluorescent photomicrographs 5 days after transplantation of antigen-containing kidneys into preimmunized recipients. Typical
granular glomerular capillary wall deposits of sheep IgG (A) and rat IgG (B) are seen in complement-depleted (group lD) recipients. Similar
deposits were seen in normo-complementemic (group lA) recipients. Rat C3 is absent in complement-depleted recipients (C), but it is present in
normo-complementemic recipients (D) in a pattern similar to that of sheep and rat IgG. (Original magnification, x400)
autologous rat antibody with the planted heterologous sheep
IgG as described by Van Es et al [21].
Experiments were done in three related models all using
sheep y2 IgG as a planted subepithelial antigen. In the native
kidney model, onset of the naturally-occurring autologous
phase of PHN was accelerated by preimmunizing rats with
sheep IgG before the administration of sheep anti-Fx1A anti-
body. Because autologous phase proteinuria only appeared 8
days after induction of PHN, and newly formed autologous
anti-sheep IgG antibody may have complexed with sheep IgG
still in the circulation, a second model was developed, in which
kidneys containing planted sheep IgG were transplanted into
preimmunized hosts. This shortened the lag phase between first
exposure to circulating rat anti-sheep IgG and onset of protein-
uria to 3 to 5 days allowing adequate depletion of complement
throughout the study. It also prevented circulating immune
complex formation. Preimmunization, however, made neutro-
phil depletion for 5 days difficult. The third model, in which
kidneys containing planted antigen were transplanted into non-
immunized hosts in whom an "autologous" phase was then
passively induced with rat anti-sheep IgG, avoided the need for
preimmunization and possible interference by cell-mediated
immunity. It also further hastened the onset of proteinuria to 2
days after first exposure to antibody during which time com-
plete depletion of leukocytes was easily achieved.
Validity of these models for the study of proteinuria produced
by an in situ reaction of host antibody with an exogenous
antigen (sheep anti-Fx IA) depends on the absence of nephro-
toxicity of the planted sheep IgG antibody. We have previously
shown that the y2 subclass of sheep anti-Fx1A reacts in situ
with a fixed glomerular antigen to form subepithelial immune
deposits but does not fix complement in vivo or in vitro nor
cause proteinuria [71. These findings were confirmed in this
study and further substantiated by showing that abrogation of
the host response to the planted sheep antibody prevented the
appearance of proteinuria. Studies in which one native kidney
was left in the recipient after transplantation also excluded a
pathogenic role for putative circulating immune complexes
which might have been formed by release of planted sheep IgG
from transplanted kidneys and its reaction with circulating rat
anti-sheep IgG. Such kidneys were entirely negative for rat and
sheep IgG by IF when removed after 4 days.
The validity of these models as examples of proteinuria due
to in situ, subepithelial immune deposit formation thus estab-
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lished, the role of complement was studied. Sequential IF
studies showed in vivo glomerular fixation of rat C3 4 hr after
exposure to rat IgG in accelerated autologous phase or passive
autologous phase transplanted kidneys. The essential require-
ment of complement for the development of proteinuria was
demonstrated by the total abrogation of proteinuria in pre-
immunized, complemented-depleted rats that received antigen-
containing kidneys. Since preimmunized rats were actively
producing antibody at the time of transplantation, and glomeru-
lar deposits of rat IgG were similar by IF in complement-
depleted and control rats, it is unlikely that the beneficial effect
of CVF was the result of any possible suppressive effect on the
immune response [22,23]. We have also previously established
that CVF does not influence the glomerular deposition of
circulating antibody [71.
Contrary to the mechanism of complement-mediated injury in
the Arthus reaction [24] and the heterologous phase of some
anti-GBM nephritis models [2, 14] in which tissue damage is
caused by neutrophils [2, 5, 61, no role could be demonstrated
for neutrophils or other inflammatory cells in this study.
Sequential histological studies of glomeruli did not reveal any
neutrophil infiltration. Occasional mononuclear cells seen in
glomeruli by electron microscopy, though adherent to endothe-
hal cells, did not appear to displace them or produce basement
membrane damage at a time when rats were markedly protein-
uric. Furthermore, selective depletion of neutrophils with anti-
PMN serum and nonselective depletion of inflammatory cells
with lethal irradiation had no ameliorating effect on proteinuria
in the passive autologous-phase transplant model, thus suggest-
ing the purely humoral nature of the lesion. However, the
possibility that the few remaining cells in the circulation in
depleted animals contributed to the lesion cannot be excluded
totally by our data.
The cell-independent mechanism by which complement al-
ters glomerular permeability in these models of membranous
nephropathy and in the PHN model [7] is unknown. We have
speculated that it may represent a membranolytic effect of the
terminal complement components [1, 71, similar to that respon-
sible for cell lysis [25], somewhere in the distal layers of the
capillary wall. Recent studies in idiopathic membranous
nephropathy and systemic lupus erythematosus in humans have
demonstrated the presence of neoantigens of the membrane-
attack complex of complement in glomerular capillary walls by
IF [26, 27], a finding which is consistent with, but does not
confirm, such a hypothesis. In this study, the epithelial cell
membrane and slit diaphragm alterations in the region of
immune deposits are prominent and could reflect such a mecha-
nism. A similar neutrophil-independent [28], complement-de-
pendent [29] process has been observed in antibody-mediated,
hyperacute, cardiac, allograft rejection in presensitized rats and
possible effects of complement-mediated mast cell degranula-
tion or a direct lytic action of complement on sarcolemma
suggested.
There is also no readily apparent explanation for the absence
of neutrophils in glomeruli despite activation of complement. It
is possible that the site at which immune deposits form in the
subepithelial space, and interposition of the more proximal
layers of the glomerular filtration barrier, renders the deposits
inaccessible to circulating inflammatory cells for immune ad-
herence. The direction of fluid flux might also favor the
movement of complement-derived chemotaxins toward Bow-
man's space and away from potentially responsive neutrophils.
Proteinuria, mediated by an in situ immune reaction of IgG and
anti-IgG on the capillary wall, has also been studied in an
accelerated autologous phase model of anti-GBM nephritis in
rats [311 and a passive autologous phase model of anti-GBM
nephritis in rabbits [32]. In these studies, in which the planted
antigen was within the GBM, probably in the lamina densa or
lamina rara interna, inflammatory lesions resulted which were
not altered by complement-depletion and were mediated by
mononuclear phagocytes [31, 32]. In our study, the in situ
formation of IgG-anti-IgG immune complexes in the subepithe-
hal space produced complement-dependent, cell-independent
proteinuria. These results suggest that the site of glomerular
immune deposit formation may be a more important factor in
determining the bland nature of the glomerular lesion which
results than the nature of the immune reactants involved as
others have suggested [301.
An interesting, though apparently unrelated, finding was the
presence of a focal, predominantly perivascular interstitial
infiltrate of mononuclear cells in transplanted kidneys. Its
occurrence appeared to depend on the presence of TBM
deposits of both sheep IgG and rat IgG but not on the presence
of C3. Thus sheep IgG deposits alone on the TBM were not
accompanied by interstitial nephritis and C3 depletion did not
prevent it. That the interstitial nephritis was not, in any way,
responsible for proteinuria was demonstrated by the observa-
tions that: (1) Antigen-containing transplanted kidneys, in C3-
depleted, preimmunized recipients, were not proteinuric de-
spite the presence of an interstitial infiltrate; and (2) antigen-
containing transplanted kidneys, in recipients who were
passively given anti-sheep IgG, were proteinuric but did not
have interstitial nephritis.
These results confirm our previous studies [7] and demon-
strate that complement-dependent, noninflammatory glomeru-
lar injury is characteristic of the experimental membranous
nephropathy in rats which results from the in situ reaction of a
complement-fixing antibody with a resident antigen, irrespec-
tive of whether the antigen is an intrinsic glomerular component
as in the PHN model, or an exogenous substance such as IgG as
in the present studies. The relevance of this mechanism to
deposit formation initiated by other exogenous antigens planted
in a subepithelial location is suggested, but not established, by
this model. Our findings also suggest that the morphologic
appearance and mediation of glomerular injury may be as much
dependent on the site of immune reaction as on the nature of the
immune reactants involved.
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